TOKYO, June 2 -- Prime Minister and His Cabinet issued the following information: [Provisional translation] On June 2, commencing at 2:30 p.m. for approximately 30 minutes, Ms. TAKAICHI Sanae, Prime Minister of Japan, held a meeting with the following representatives attending the Island States Ocean Summit: H.E. Mr. Surangel S. Whipps, Jr., President of Palau; H.E. Dr. Hilda C. Heine, President of the Marshall Islands; H.R.H. Crown Prince Haakon of Norway; Hon. Mr. Mark Brown, Prime Minister ...
Tokyo, June 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061748) titled 'A Study Using Transcranial Magnetic Stimulation Testing to Examine the Brain Excitation and Inhibition in Eating Disorders' on June 2. Study Type: Observational Primary Sponsor: Institute - Chiba University Condition: Condition - Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder Classification by malignancy - Others Genomic information - NO Objective: Narrative ...
Tokyo, June 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061421) titled 'Clinical Outcomes of Left Bundle Branch Area and BachmaNn BunDle Pacing: Multicenter ReAl-World Registry in Kanagawa (LANDMARK study)' on June 2. Study Type: Observational Primary Sponsor: Institute - LANDMARK study investigators Condition: Condition - All patients undergoing pacemaker-related procedures at participating institutions will be included. Pacemaker therapy ...
TOKYO, June 2 -- Prime Minister and His Cabinet issued the following information: [Provisional translation] On June 2, 2026, Prime Minister Takaichi held a meeting with representatives attending the Island States Ocean Summit, at the Prime Minister's Office. Disclaimer: Curated by HT Syndication....
TOKYO, June 2 -- Prime Minister and His Cabinet issued the following information: [Provisional translation] On June 2, 2026, Prime Minister Takaichi received a courtesy call from Mr. Ajay Banga, President of the World Bank Group at the Prime Minister's Office. Disclaimer: Curated by HT Syndication....
Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061774) titled 'The Effects of Local Anesthetics on the Proliferation and Multipotency of Synovial Stem Cells' on June 2. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control Primary Sponsor: Institute - Institute of Science Tokyo Condition: Condition - Knee Osteoarthritis Classifica...
Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061771) titled 'Analysis of the relationship and mechanisms between dental anxiety and autonomic nervous system responses in dental phobia' on June 2. Study Type: Observational Primary Sponsor: Institute - Kagoshima University Condition: Condition - the impacted mandibular third molar Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - Thi...
Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061767) titled 'Effects of Balloon-Blowing Training on Respiratory Function' on June 2. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -but assessor(s) are blinded Control - Active Primary Sponsor: Institute - International University of Health and Welfare Condition: Condition - Healthy university students Classification by ...
Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061766) titled 'Pediatric Enteral Assessment of Real-world Long-term outcomes with Teduglutide for Short Bowel Syndrome in Japan' on June 2. Study Type: Observational Primary Sponsor: Institute - Takeda Pharmaceutical Company Limited Condition: Condition - Short Bowel Syndrome Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - The objecti...
Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061763) titled 'ALECENSA Drug Use Surveillance' on June 2. Study Type: Observational Primary Sponsor: Institute - Chugai Pharmaceutical Co. Ltd Condition: Condition - To confirm the following under actual conditions of use of Alectinib Hydrochloride Capsules (hereinafter, this drug) in ALK fusion gene-positive patients with advanced or recurrent solid tumors Non-small cell lung cancer ...